Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects
Open accessThe DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
Chronic liver dysfunction or injury is a serious health problem worldwide. Chronic liver disease involves a wide range of liver pathologies that include fatty liver, hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. The efficiency of current synthetic agents in treating chronic liver disease is not satisfactory and they have undesirable side effects. Thereby, numerous medicinal herbs and phytochemicals have been investigated as complementary and alternative treatments for chronic liver diseases. Since some herbal products have already been used for the management of liver diseases in some countries or regions, a systematic review on these herbal medicines for chronic liver disease is urgently needed. Herein, we conducted a review describing the potential role, pharmacological studies and molecular mechanisms of several commonly used medicinal herbs and phytochemicals for chronic liver diseases treatment. Their potential toxicity and side effects were also discussed. Several herbal formulae and their biological effects in chronic liver disease treatment as well as the underlying molecular mechanisms are also summarized in this paper. This review article is a comprehensive and systematic analysis of our current knowledge of the conventional medicinal herbs and phytochemicals in treating chronic liver diseases and on the potential pitfalls which need to be addressed in future study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263 · cited 15×
“In a study with a NAFL cellular model, GP extract was efficient in inhibiting the accumulation of cholesterol and triglycerides as well as preventing oxidative stress in liver cells.”
BackgroundInfluentialLiver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Mokdad, A. A., Lopez, A. D., Shahraz, S., Lozano, R., Mokdad, A. H., Stanaway, J., Murray, C. J., & Naghavi, M. (2014) · BMC Medicine · doi:10.1186/s12916-014-0145-y · Cited by 1,129 · cited 1×
“95% of the global deaths [111].”
Fugh-Berman, A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06457-0 · Cited by 1,099
Mechanisms of hepatic fibrogenesis
Lee, U. E., & Friedman, S. L. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.005 · Cited by 923
(2006) · Pharmacodynamic Basis of Herbal Medicine, Second Edition · doi:10.1201/9781420006452.ch4 · Cited by 905
Invited Review: Pathology, Etiology, Prevention, and Treatment of Fatty Liver in Dairy Cows
Bobe, G., Young, J. W., & Beitz, D. C. (2004) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(04)73446-3 · Cited by 877 · cited 1×
“Fatty liver disease is usually induced by excessive alcohol consumption or metabolic disorders such as obesity, insulin resistance and dyslipidemia [73].”
BackgroundPaik, Y.-H., Schwabe, R. F., Bataller, R., Russo, M. P., Jobin, C., & Brenner, D. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50182 · Cited by 651 · cited 1×
“Recent studies suggest that NF-κB, Toll-like receptors and β-cathepsin may be involved in fibrosis regulation [117,118].”
BackgroundPharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Imanshahidi, M., & Hosseinzadeh, H. (2008) · Phytotherapy Research · doi:10.1002/ptr.2399 · Cited by 634
Herb-Drug Interactions: A Literature Review
Hu, Z., Yang, X., Ho, P. C. L., Chan, S. Y., Heng, P. W. S., Chan, E., Duan, W., Koh, H. L., & Zhou, S. (2005) · Drugs · doi:10.2165/00003495-200565090-00005 · Cited by 633 · cited 1×
“Thus, for patients taking warfarin, Salvia miltiorrhiza Bunge treatment should be avoided to decrease the risk of bleeding complications [235–237].”
BackgroundBataller, R., Schwabe, R. F., Choi, Y. H., Yang, L., Paik, Y. H., Lindquist, J., Qian, T., Schoonhoven, R., Hagedorn, C. H., Lemasters, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18212 · Cited by 548 · cited 1×
“For example, c-Jun N-terminal kinase regulates apoptosis of hepatic cells and induces the secretion of inflammatory cytokines by stellate cell [113].”
BackgroundIsbrucker, R. A., & Burdock, G. A. (2006) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2006.06.002 · Cited by 501 · cited 1×
“2 mg/kg [223].”
Marra, F., Efsen, E., Romanelli, R. G., Caligiuri, A., Pastacaldi, S., Batignani, G., Bonacchi, A., Caporale, R., Laffi, G., Pinzani, M., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.9365 · Cited by 409 · cited 1×
“PPAR-γ ligands suppress the fibrogenic process in stellate cell in vitro and in vivo [116].”
BackgroundSilybin and the liver: From basic research to clinical practice
Loguercio, C. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i18.2288 · Cited by 375 · cited 1×
“Generally, silymarine and silybinin have not shown any significant side effects or toxicity in previous study, except for the above mentioned ones [225–227].”
Pathological Features of Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.056 · Cited by 346 · cited 1×
“In both AFL and NAFL, steatosis will sensitize the liver tissue to the induction of inflammation by oxidative stress and will further develop steatohepatitis [77].”
BackgroundParés, A., Planas, R., Torres, M., Caballería, J., Viver, J. M., Acero, D., Panés, J., Rigau, J., Santos, J., & Rodés, J. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80285-7 · Cited by 331 · cited 1×
“However, the effects of silymarin on survival rate or the disease progression of liver cirrhosis remains controversial in clinical practice [137].”
BackgroundHepatic fibrosis: molecular mechanisms and drug targets
Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095906 · Cited by 325 · cited 1×
“Apoptotic bodies derived from the damaged hepatic cells can further activate Kupffer cells to secrete transforming growth factor beta 1, endothelial growth factor and platelet-derived growth factor, which can promote the transformation of activated hepatic stellate cells into myofibroblasts [19].”
BackgroundNotarbartolo, M., Poma, P., Perri, D., Dusonchet, L., Cervello, M., & D'Alessandro, N. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.10.051 · Cited by 317 · cited 1×
“However, there are no significant changes in NF-kB activation, which indicated the anti-cancer effects by curcumin may be related to other mechanisms [180].”
BackgroundA phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients
Flaig, T. W., Gustafson, D. L., Su, L.-J., Zirrolli, J. A., Crighton, F., Harrison, G. S., Pierson, A. S., Agarwal, R., & Glodé, L. M. (2007) · Investigational New Drugs · doi:10.1007/s10637-006-9019-2 · Cited by 315 · cited 1×
“A phase I clinical trial in prostate cancer patients demonstrated that high dose silibinin (13 g/day) may cause hyperbilirubinemia and increase alanine aminotransferase levels [224].”
BackgroundPeng, W., Qin, R., Li, X., & Zhou, H. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.05.007 · Cited by 308 · cited 1×
“has antiviral and hepatoprotective effects, and the major active ingredients may include anthraquinones, resveratrol and polydatin [45].”
BackgroundLiver disease and diabetes mellitus.
Na, B., Herrine, S. K., & Rubin, R. A. (2001) · PubMed · Cited by 299
Wang, N., Feng, Y., Zhu, M., Tsang, C., Man, K., Tong, Y., & Tsao, S. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22869 · Cited by 289 · cited 1×
“The mechanisms may be related with activation of Beclin-1 to induce mitochondrial apoptosis and suppression of mTOR to induce autophagic cell death in HCC by berberine [160].”
BackgroundSelf-citationHsu, C.-L., & Yen, G.-C. (2007) · British Journal of Nutrition · doi:10.1017/s000711450774686x · Cited by 279 · cited 1×
“These results indicated that gallic acid treatment can inhibit NAFLD-related hepatosteatosis, dyslipidaemia and oxidative stress in rats [96].”
BackgroundProspective study of chemoprevention of hepatocellular carcinoma with sho-saiko-to (TJ-9)
Oka, H., Yamamoto, S., Kuroki, T., Harihara, S., Marumo, T., Kim, S. R., Monna, T., Kobayashi, K., & Tango, T. (1995) · Cancer · doi:10.1002/1097-0142(19950901)76:5<743::aid-cncr2820760506>3.0.co;2-v · Cited by 269 · cited 1×
“Some studies found that XCHT could prevent tumor formation in patients with hepatic cirrhosis, especially in those without HBV infection [199].”
BackgroundThe Role of Smad3 in Mediating Mouse Hepatic Stellate Cell Activation
Schnabl, B., Kweon, Y. O., Frederick, J. P., Wang, X.-F., Rippe, R. A., & Brenner, D. A. (2001) · Hepatology · doi:10.1053/jhep.2001.25349 · Cited by 258 · cited 1×
“The TGF-β1–activated Smad-signaling pathway modulates experimental hepatic fibrosis in vitro and is a potential target for anti-fibrosis [115].”
BackgroundKidd, P. M., & Head, K. A. (2005) · PubMed · Cited by 253
Acute toxicity of berberine and its correlation with the blood concentration in mice
Kheir, M. M., Wang, Y., Hua, L., Hu, J., Li, L., Lei, F., & Du, L. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.01.033 · Cited by 235 · cited 1×
“6103 mg/kg [212,213].”
Alcoholic liver disease: Pathogenesis, management, and novel targets for therapy
Orman, E. S., Odena, G., & Bataller, R. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12030 · Cited by 232 · cited 1×
“Excessive alcohol consumption, virus infection, obesity, diabetes and drug-induced liver damage are the leading causes of these liver diseases [3–5].”
BackgroundMultiple Effects of Silymarin on the Hepatitis C Virus Lifecycle
Wagoner, J., Negash, A., Kane, O. J., Martinez, L. E., Nahmias, Y., Bourne, N., Owen, D. M., Grove, J., Brimacombe, C., McKeating, J. A., et al. (2010) · Hepatology · doi:10.1002/hep.23587 · Cited by 232
Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer
Feher, J., & Lengyel, G. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112798868818 · Cited by 218 · cited 1×
“The chemopreventive effect of silymarin on HCC has been demonstrated in both in vitro and in vivo studies [162].”
BackgroundDeugnier, Y. M., Guyader, D., Crantock, L., Lopez, J.-M., Turlin, B., Yaouanq, J., Jouanolle, H., Campion, J.-P., Launois, B., Halliday, J. W., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90856-8 · Cited by 196
The epidemiology, pathogenesis and histopathology of fatty liver disease
Levene, A. P., & Goldin, R. D. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04145.x · Cited by 192 · cited 1×
“Of those with ASH, approximately 40% will develop cirrhosis [76].”
BackgroundSilymarin treatment of viral hepatitis: a systematic review
Mayer, K. É., Myers, R. P., & Lee, S. S. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00636.x · Cited by 188 · cited 1×
“developed a systematic review for the therapeutic effects of silymarin in treating chronic viral Hepatitis B and C, and the results demonstrated that silymarin can down-regulate serum transaminases in chronic viral hepatitis patients, but the liver histology or serum viral content have not been affected by silymarin […”
BackgroundConn, J. W. (1968) · JAMA · doi:10.1001/jama.1968.03140330034006 · Cited by 177 · cited 1×
“Previous study has proved that glycyrrhizin can lead to pseudoaldosteronism which will cause aldosteronopenia, hypokalemia, hypertension, and inhibited plasma renin activity [219].”
BackgroundGallic Acid Ameliorated Impaired Glucose and Lipid Homeostasis in High Fat Diet-Induced NAFLD Mice
Chao, J., Huo, T.-I., Cheng, H.-Y., Tsai, J.-C., Liao, J.-W., Lee, M.-S., Qin, X.-M., Hsieh, M.-T., Pao, L.-H., & Peng, W.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096969 · Cited by 168 · cited 1×
“The hepatoprotective effect by gallic acid may be related to regulation of the metabolism of choline, amino acids, glucose, lipid and gut-microbiota in mice [95].”
BackgroundYOUNOSSI, Z. M. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03710.x · Cited by 166 · cited 1×
“For advanced patients with steatohepatitis, there are still no effective treatments [79,80].”
BackgroundMarra, F., Arrighi, M. C., Fazi, M., Caligiuri, A., Pinzani, M., Romanelli, R. G., Efsen, E., Laffi, G., & Gentilini, P. (1999) · Hepatology · doi:10.1002/hep.510300406 · Cited by 161 · cited 1×
“The focal adhesion kinase PI3K-Akt–signaling pathway regulates agonist-induced fibrogenic actions in stellate cell [114].”
BackgroundInteraction Between Warfarin and Danshen (Salvia miltiorrhiza)
Chan, T. Y. K. (2001) · Annals of Pharmacotherapy · Cited by 159
Guo, H., Liu, D.-H., Ma, Y., Liu, J.-F., Wang, Y., Du, Z., Wang, X., Shen, J., & Peng, H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.150 · Cited by 152 · cited 1×
“Baicalin was also found to be effective in modulating lipid metabolism and suppressing systemic inflammation in high-fat feeding rat liver and the mechanism may be related to the regulation of AMPK-alpha signaling pathway [105,106].”
BackgroundChronic liver disease mortality in the United States, 1990-1998
Vong, S., & Bell, B. P. (2004) · Hepatology · doi:10.1002/hep.20049 · Cited by 149 · cited 1×
“Among the various forms of chronic liver diseases, the most widely spread types include viral hepatitis, alcoholic or nonalcoholic fatty liver disease, autoimmune hepatitis, cirrhosis and hepatocellular carcinoma [2].”
BackgroundCytotoxicity and Anti-Hepatitis B Virus Activities of Saikosaponins fromBupleurumSpecies
Chiang, L., Ng, L., Liu, L., et al. (2003) · Planta Medica · doi:10.1055/s-2003-42797 · Cited by 148 · cited 1×
“Previous study on saikosaponin C has found that the HBV-infected liver cells cultured with saikosaponin C exhibited a remarkable lower expression of HBV antigen in culture medium, and this antiviral effect was not due to the cytotoxicity of saikosaponin C [50].”
BackgroundBirth Outcome in Relation to Licorice Consumption during Pregnancy
Strandberg, T. E. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.11.1085 · Cited by 142 · cited 1×
“Another study also found that high dose administration of glycyrrhizin for pregnant women will increase the premature birth rate [221].”
BackgroundThe epidemiology of fatty liver
Bellentani, S., Bedogni, G., Miglioli, L., & Tiribelli, C. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00002 · Cited by 142 · cited 1×
“In Western countries, fatty liver disease is the most common liver disease, the prevalence of which ranges from about 20%–60% [74].”
BackgroundTherapeutic targeting of liver inflammation and fibrosis by nanomedicine.
Bartneck, M., Warzecha, K. T., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.02 · Cited by 141 · cited 1×
“The macrophages (Kupffer cells) and other liver-resident cells such as hepatic stellate cells and sinusoidal endothelial cells promote the formation and emitting of pro-inflammatory signals of cytokines, chemokines, lipid messengers and reactive oxygen species (ROS) and activate the inflammatory response that leads to…”
BackgroundTreatment of chronic liver diseases with traditional Chinese medicine
Wang, B.-E. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02100.x · Cited by 138 · cited 1×
“Although there have been remarkable progress in discovering treatment of chronic liver diseases over the last several decades, most of the therapies still do not yield satisfactory outcomes in patients [6].”
BackgroundAntiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro
Matsumoto, Y., Matsuura, T., Aoyagi, H., Matsuda, M., Hmwe, S. S., Date, T., Watanabe, N., Watashi, K., Suzuki, R., Ichinose, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068992 · Cited by 138 · cited 2×
“Recently, glycyrrhizin has been found to suppress HCV particle release as well as the activity of phospholipase A2 (PLA2) [24].”
BackgroundAnti-hepatitis B Virus Activities of Astragaloside IV Isolated from Radix Astragali
Wang, S., Li, J., Huang, H. Y., Gao, W. Y., Zhuang, C., Li, B., Zhou, P., & Kong, D. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.132 · Cited by 135 · cited 1×
“) Bunge for inhibiting HBV activities may be triterpenoid saponin [72].”
BackgroundTariq, Z., Green, C., & Hodson, L. (2014) · Liver International · doi:10.1111/liv.12523 · Cited by 132
Seeff, L. B., Curto, T. M., Szabó, G., Everson, G. T., Bonkovsky, H. L., Dienstag, J. L., Shiffman, M. L., Lindsay, K. L., Lok, A. S.-F., Bisceglie, A. M. D., et al. (2007) · Hepatology · doi:10.1002/hep.22044 · Cited by 132 · cited 1×
“Long-term use of silymarin may provide benefits to patients with chronic Hepatitis C [136].”
BackgroundManjrekar, A., Jisha, V., Bag, P. P., Adhikary, B., Pai, M. M., Hegde, A. H., & Nandini, M. (2008) · PubMed · Cited by 126
Drug-induced liver injury: a clinical update
Ghabril, M., Chalasani, N., & Björnsson, E. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283383c7c · Cited by 123 · cited 1×
“Age, genetic variability, female sex, and previous drug-induced hepatitis are the key predisposing risk factors to drug-induced hepatitis [12].”
BackgroundNutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta‐analysis
Fialla, A. D., Israelsen, M., Hamberg, O., Krag, A., & Gluud, L. L. (2015) · Liver International · doi:10.1111/liv.12798 · Cited by 122 · cited 1×
“So far, there is no treatment that can radically reverse cirrhosis except for liver transplantation, but the supply of liver allografts is far short of the number of potential recipients [119].”
BackgroundZhang, L., Wang, G., Hou, W., Li, P., Dulin, A., & Bonkovsky, H. L. (2009) · Hepatology · doi:10.1002/hep.23384 · Cited by 121 · cited 1×
“is one of the most frequently used herbs in the traditional Chinese medicine for chronic hepatitis treatment [46].”
BackgroundGao, J., Liu, Z. J., Chen, T., & Zhao, D. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2013.879188 · Cited by 117 · cited 1×
“) Bunge could modulate immunologic system, inhibit virus growth and suppress cancer proliferation [69,70].”
BackgroundLoguercio, C., Federico, A., Trappoliere, M., Tuccillo, C., de Sio, I., Di Leva, A., Niosi, M., D’Auria, M. V., Capasso, R., Blanco, C. D. V., et al. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9703-2 · Cited by 116 · cited 1×
“In addition, a significant improvement in liver enzyme levels, indexes of liver fibrosis, and hyperinsulinemia have been observed in siliphos treatment group [101].”
BackgroundSaikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry
Lin, L., Chung, C.-Y., Hsu, W.-C., Chang, S.-P., Hung, T.-C., Shields, J. A., Russell, R. S., Lin, C., Li, C., Yen, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.040 · Cited by 115
Checker, R., Patwardhan, R. S., Sharma, D., Menon, J., Thoh, M., Bhilwade, H. N., Konishi, T., & Sandur, S. K. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.006 · Cited by 115
Hepatoprotective effects of baicalein against CCl4-induced acute liver injury in mice
Huang, H., Wang, Y.-J., Zhang, Q.-Y., Liu, B., Wang, F.-Y., Li, J.-J., & Zhu, R.-Z. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i45.6605 · Cited by 115
Zhang, H., Li, C., Kwok, S.-T., Zhang, Q., & Chan, S. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/208349 · Cited by 115 · cited 1×
“This herbaceous perennial plant is widely distributed in the world and prefers to grow in humid environment such as the valley or forest [44].”
BackgroundXi, Y., Wu, M., Li, H., Dong, S., Luo, E., Gu, M., Shen, X. Z., Jiang, Y., Liu, Y., & Liu, H. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374037 · Cited by 114
Feng, Y., Wang, N., Ye, X., Li, H., Feng, Y., Cheung, F., & Nagamatsu, T. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.09.032 · Cited by 114 · cited 1×
“The hepatoprotective effect by CRAE on CCl4-induced chronic liver hepatotoxicity such as fibrosis has been reported by many studies [120,121].”
BackgroundSelf-citationLi, R., Xu, L., Liang, T., Li, Y., Zhang, S., & Duan, X. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.059 · Cited by 112 · cited 1×
“Through down-regulating the TNF-alpha and NF-kB expression by puerarin treatment, the inflammation response in liver tissue was relieved and the metabolic function was also improved [126].”
BackgroundHepatitis B and C in pregnancy: a review and recommendations for care
Dunkelberg, J. C., Berkley, E. M. F., Thiel, K. W., & Leslie, K. K. (2014) · Journal of Perinatology · doi:10.1038/jp.2014.167 · Cited by 111 · cited 1×
“In some developed countries, due to the widespread vaccination of HBV, Hepatitis C has become the most common cause of viral hepatitis since the 1980s [10].”
BackgroundEffects of dietary baicalin supplementation on iron overload-induced mouse liver oxidative injury
Zhao, Y., Li, H., Gao, Z., & Xu, H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.11.060 · Cited by 108 · cited 1×
“25% and 1%) also exhibited protective effects on liver injury in iron overload mouse, the mechanism of which may be associated with the iron chelation and antioxidant activities of baicalin [61].”
BackgroundDisplacement of Bilirubin from Albumin by Berberine
Chan, E. (1993) · Neonatology · doi:10.1159/000243932 · Cited by 106 · cited 1×
“Some other studies believed that berberine treatment for pregnant women may lead to hemolytic disease in newborns; berberine treatment for children may lead to severe jaundice and acute hemolysis [215–218].”
BackgroundAntifibrotic effects of chronic baicalein administration in a CCl4 liver fibrosis model in rats
Sun, H., Che, Q., Zhao, X. S., & Pu, X. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.01.002 · Cited by 106
Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells
Ramakrishnan, G., Muzio, L. L., Elinos-Báez, C. M., Jagan, S., Augustine, T. A., Kamaraj, S., Anandakumar, P., & Devaki, T. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2008.00581.x · Cited by 105 · cited 1×
“The potential molecular mechanisms are associated with reduced mitochondrial transmembrane potential of liver cells followed by increased expression of cytosolic cytochrome c and pro-apoptotic proteins such as Bax, p53, caspase-3 and APAF-1 and down-regulation of anti-apoptotic proteins (survivin and Bcl-2) and prolif…”
BackgroundBuzzelli, G., Moscarella, S., Giusti, A., Duchini, A., Marena, C., & Lampertico, M. (1993) · PubMed · Cited by 104
Potent effects of dioscin against obesity in mice
Liu, M., Xu, L., Yin, L., Qi, Y., Xu, Y., Han, X., Zhao, Y., Sun, H., Yao, J., Lin, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep07973 · Cited by 101
Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang)
Itoh, S., Marutani, K., Nishijima, T., Matsuo, S., & Itabashi, M. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02212712 · Cited by 100 · cited 1×
“Some case reports in Japan and Taiwan have revealed that patients exhibited acute drug-induced liver injury after treatment with Xiao Chai Hu Tang, and Scutellaria baicalensis Georgi was believed to be one of the toxic ingredients in this herbal formula [240,241].”
BackgroundYe, X., Feng, Y., Tong, Y., Ng, K., Tsao, S., Lau, G. K. K., Sze, S. C. W., Zhang, Y., Tang, J., Shen, J., et al. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.04.003 · Cited by 99 · cited 1×
“The hepatoprotective effect by CRAE on CCl4-induced chronic liver hepatotoxicity such as fibrosis has been reported by many studies [120,121].”
BackgroundSelf-citationShi, K., Fan, Y., Liu, W., Li, L., Chen, Y., & Zheng, M. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1836-0 · Cited by 97 · cited 1×
“[90].”
Fujisawa, Y., Sakamoto, M., Matsushita, M., Fujita, T., & Nishioka, K. (2000) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2000.tb02566.x · Cited by 97 · cited 1×
“Further studies demonstrated that glycyrrhizin suppresses the lytic pathway in which the membrane attack complex is formed [25].”
BackgroundCHANG, J., Liu, H., Wang, K., CHEN, M., CHIANG, L., HUA, Y., & Lin, C. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2004.12.006 · Cited by 97 · cited 1×
“, it could inhibit the production of HBV DNA at a low dose (10 μg/mL) [47].”
BackgroundGenus Phyllanthus for chronic hepatitis B virus infection: a systematic review
Liu, J., Lin, H., & McIntosh, H. (2001) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2001.00307.x · Cited by 96 · cited 1×
“When compared with interferon (IFN) and placebo, the therapeutic effects of combination treatment of Phyllanthus niruri L and IFN was better [43].”
ResultDing, R., Tian, K., Cao, Y., Bao, J., Wang, M., He, C., Yuanjia, H., Su, H., & Wan, J. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf502990n · Cited by 95 · cited 1×
“In addition, PNS can protect liver cells from CYP2E1-mediated oxidative stress [88,89].”
BackgroundLi, J., Pan, Y., Kan, M., Xiao, X., Wang, Y., Guan, F., Zhang, X., & Chen, L. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.12.211 · Cited by 94 · cited 1×
“The further mechanism study showed that the anti-fibrosis effects by berberine may be induced by activation of AMPK, blockade of Nox4 and Akt expression [123].”
BackgroundXing, L., Zhang, L. R., Liu, T., Hua, Y., Zheng, P., & Ji, G. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.036 · Cited by 93 · cited 1×
“Berberine can also enhance insulin resistance of nonalcoholic fatty liver disease by increasing the expression of insulin receptor substrate-2 (IRS-2) and regulating the insulin signaling pathway [82].”
BackgroundHerbal Products: Benefits, Limits, and Applications in Chronic Liver Disease
Prete, A. D., Scalera, A., Iadevaia, M. D., Miranda, A., Zulli, C., Gaeta, L. M., Tuccillo, C., Federico, A., & Loguercio, C. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/837939 · Cited by 93 · cited 1×
“According to the previous studies, medicinal herbs and phytochemicals could protect the liver by several mechanisms such as eliminating virus, blocking fibrogenesis, inhibiting oxidative injury and suppressing tumorigenesis [7,8].”
BackgroundWang, N., Zhu, M., Wang, X., Tan, H.-Y., Tsao, S.-W., & Feng, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.05.027 · Cited by 93 · cited 1×
“In vivo study also showed that when miR-23a expression was inhibited, the berberine-induced tumor suppression in mice was attenuated [157].”
BackgroundSelf-citationXue, M., Zhang, L., Yang, M., Zhang, W., Li, X.-M., Ou, Z., Li, Z., Liu, S.-H., Li, X., & Yang, S. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s84565 · Cited by 92 · cited 1×
“Further study of the mechanisms revealed that BBR-SLNs can inhibit the expression of lipogenic genes such as stearoyl-CoA desaturase (SCD1), fatty acid synthase (FAS), and sterol regulatory element-binding protein 1c (SREBP1c), and increase the expression of lipolytic gene such as carnitine palmitoyltransferase-1 (CPT…”
BackgroundSömjen, D., Knoll, E., Vaya, J., Stern, N., & Tamir, S. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.04.003 · Cited by 92 · cited 1×
“Both in vitro and in vivo studies of the licorice extracts exhibit estrogen-like activities which may lead to a high risk of heart disease in women [220].”
BackgroundReduction of Serum Testosterone in Men by Licorice
Armanini, D., Bonanni, G., & Palermo, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411515 · Cited by 90 · cited 1×
“For male patients, licorice extracts can lead to down-regulation of serum testosterone secretion and cause impotency [222].”
BackgroundGuo, C., Xu, L., He, Q., Liang, T., Duan, X., & Li, R. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.02.051 · Cited by 88
Lee, W., Chiu, L. C. M., & Yeung, J. H. K. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.08.013 · Cited by 88 · cited 1×
“However, other tanshinones in the study have not shown significant effect in inducing apoptosis in HCC cells [169].”
BackgroundBlaising, J., Lévy, P. L., Gondeau, C., Phelip, C., Varbanov, M., Teissier, E., Ruggiero, F., Polyak, S. J., Oberlies, N. H., Ivanovic, T., et al. (2013) · Cellular Microbiology · doi:10.1111/cmi.12155 · Cited by 87 · cited 1×
“Silibinin can influence the formation of both clathrin-coated pits and vesicles in liver cells and destroy the clathrin endocytic pathway by interfering with the absorption and trafficking of transferrin [36].”
BackgroundLiu, S., Wei, W., Shi, K., Cao, X., Zhou, M., & Liu, Z. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.05.064 · Cited by 87
Wu, S., Lin, Y., Chu, C.-C., Tsai, Y., & Chao, J. C. ‐. (2008) · Journal of Medicinal Food · doi:10.1089/jmf.2007.555 · Cited by 86 · cited 1×
“In addition, the plasma and hepatic cholesterol and triglyceride levels also decreased after saikosaponin treatment [141].”
BackgroundÖztürk, F., Gül, M., Ateş, B., Öztürk, İ. Ç., Çetin, A., Vardı, N., Otlu, A., & Yılmaz, İ. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509991322 · Cited by 85
Novak, D. J., & Lewis, J. H. (2003) · Current Opinion in Internal Medicine · doi:10.1097/00132980-200302030-00001 · Cited by 85
Zhang, B., Xu, D., Guo, Y., Ping, J., Chen, L., & Wang, H. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04819.x · Cited by 83 · cited 1×
“In addition, another study found that the myofibroblast proliferation and the expression of TGF-b1 and a-SMA were remarkably decreased after berberine treatment [122].”
BackgroundLee, W., Cheung, C. C. M., Liu, K. W. K., Fung, K., Wong, J., Lai, P. B. S., & Yeung, J. H. K. (2010) · Journal of Natural Products · doi:10.1021/np900792p · Cited by 83 · cited 1×
“The tanshinone IIA, another kind of tanshinone, exhibits pro-apoptotic effects and better synergism with doxorubicin in HCC cells [168].”
BackgroundLi, T., Li, S., Dong, Y., Zhu, R., & Liu, Y. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.08.036 · Cited by 82 · cited 1×
“Moreover, the liver biopsy results confirmed that penta-oligogalacturonide treatment at a dose of 300 mg/kg can inhibit liver steatosis in mice with high-fat diet [91].”
BackgroundSelf-citationReversal of chemical-induced liver fibrosis in Wistar rats by puerarin
Zhang, S., Ji, G., & Liu, J. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.09.002 · Cited by 82 · cited 1×
“Further study of the mechanisms confirmed that down-regulation of bcl-2 mRNA are involved in puerarin induced hepatic stellate cells apoptosis [127].”
BackgroundPlíšková, M., Vondráček, J., Křen, V., Gažák, R., Sedmera, P., Walterová, D., Psotová, J., Šimánek, V., & Machala, M. (2005) · Toxicology · doi:10.1016/j.tox.2005.06.020 · Cited by 81 · cited 1×
“Generally, silymarine and silybinin have not shown any significant side effects or toxicity in previous study, except for the above mentioned ones [225–227].”
Pan, T., Wang, P.-W., Leu, Y., Wu, T.-H., & Wu, T.-S. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.12.028 · Cited by 81
Study of liver cirrhosis over ten consecutive years in Southern China
Wang, X., Lin, S.-X., Jin, T., Wei, X., Liu, Y., Chen, Y.-M., & Wu, B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i37.13546 · Cited by 80 · cited 1×
“80%, and the other etiologies accounted for about 15% [110].”
BackgroundMulticenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B
Liu, P. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i19.2892 · Cited by 79
Serviddio, G., Bellanti, F., Stanca, E., Lunetti, P., Blonda, M., Tamborra, R., Siculella, L., Vendemiale, G., Capobianco, L., & Giudetti, A. M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.002 · Cited by 79
Mechanisms of Herb-Induced Nephrotoxicity
Allard, T., Wenner, T., Greten, H. J., & Efferth, T. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320220006 · Cited by 79 · cited 1×
“Some side effects or toxicity of herbal medicines may constitute an acute exacerbation such as allergy, while some agents may have chronic toxicity which require long-term accumulation such as some nephrotoxicity herbs [210,211].”
BackgroundProtective effects of dioscin against alcohol-induced liver injury
Xu, T., Zheng, L., Xu, L., Yin, L., Qi, Y., Xu, Y., Han, X., & Peng, J. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1148-8 · Cited by 77 · cited 1×
“Dioscin also showed an excellent protective effect against alcoholic fatty liver by relieving alcohol-induced oxidative stress, inflammatory cytokine production, mitochondrial function, apoptosis and liver steatosis in vivo [94].”
BackgroundWang, J., Guo, J., Li, H., Liu, S., & Zern, M. Α. (1998) · Liver International · doi:10.1111/j.1600-0676.1998.tb00147.x · Cited by 73
Serviddio, G., Bellanti, F., Giudetti, A. M., Gnoni, G. V., Petrella, A., Tamborra, R., Romano, A. D., Rollo, T., Vendemiale, G., & Altomare, E. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.161612 · Cited by 70 · cited 1×
“bioenergetics in nonalcoholic steatohepatitis [100].”
Acute Hepatitis Induced by Chinese Hepatoprotective Herb, Xiao-Chai-Hu-Tang
Hsu, L.-M., Huang, Y.-S., Tsay, S.-H., Chang, F.-Y., & Lee, S.-D. (2006) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(09)70119-4 · Cited by 68 · cited 1×
“Some case reports in Japan and Taiwan have revealed that patients exhibited acute drug-induced liver injury after treatment with Xiao Chai Hu Tang, and Scutellaria baicalensis Georgi was believed to be one of the toxic ingredients in this herbal formula [240,241].”
BackgroundTajiri, H., Kozaiwa, K., Ozaki, Y., Miki, K., Shimuzu, K., & Okada, S. (1991) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x91000193 · Cited by 67 · cited 2×
“The role of SCHT in liver cancer is still controversial.”
BackgroundWang, M., Wang, F., Wang, Y., Ma, X., Zhao, M., & Zhao, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078731 · Cited by 66 · cited 1×
“found that GP extracts can promote lipid metabolism, and decrease serum lipids level by down-regulating the production of trimethylamine N-oxide (TMAO) and up-regulating the secretion of phosphatidylcholine [84].”
BackgroundA review of epidemiological data on epilepsy, phenobarbital, and risk of liver cancer
La Vecchia, C., & Negri, E. (2014) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32836014c8 · Cited by 66 · cited 1×
“The five year survival rate of primary liver cancer is only 17% in the United States in 2014 and even lower in developing countries [150].”
BackgroundWu, Y., Lian, L., Wan, Y., & Nan, J. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.008 · Cited by 65
Drug-induced liver disease 2004
Lazerow, S. K., Abdi, M. S., & Lewis, J. H. (2005) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000160043.10804.60 · Cited by 63
Wang, N., Feng, Y., Tan, H., Cheung, F., Hong, M., Lao, L., & Nagamatsu, T. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.02.025 · Cited by 61 · cited 1×
“The major active ingredients in HLJD decoction, geniposide, baicalin and berberine may synergistically activate eEF2 kinase (eEF2K) and lead to eEF2 inactivation [201].”
BackgroundSelf-citationShin, K. S., Choi, H. S., Zhao, T., Suh, K. H., Kwon, I. H., Choi, S. O., & Lee, M. K. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0051-4 · Cited by 60 · cited 1×
“Berberine administration should be monitored for Parkinson's disease patients with chronic L-DOPA treatment [214].”
BackgroundAbrogation of G2/M arrest sensitizes curcumin‐resistant hepatoma cells to apoptosis
Wang, W., Chéng, J., Luo, J., & Zhuang, S. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.06.048 · Cited by 60 · cited 1×
“For curcumin-resistant liver cancer cells, a recent study has revealed that Chk1-mediated G2/M cell cycle arrest may be related with curcumin resistance and Chk1 may be a potential target for future study in reversing resistance and improving the clinical efficacy of curcumin [181].”
BackgroundDeng, G., Kurtz, R. C., Vickers, A. J., Lau, N., Yeung, K. S., Shia, J., & Cassileth, B. R. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.04.008 · Cited by 60 · cited 1×
“Moreover, the subsequent liver biopsy histology also supported the hepatoprotective effect of XCHT in HCV patients [196].”
BackgroundZhang, Y., Zhou, S., Cheng, X.-B., Yi, B., Shan, S., Wang, J., & Li, Q. F. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14108 · Cited by 58
Antimicrobial Activity of Crude Methanolic Extract from Phyllanthus niruri
Ibrahim, D., Hong, L. S., & Kuppan, N. (2013) · Natural Product Communications · doi:10.1177/1934578x1300800422 · Cited by 57 · cited 1×
“Phyllanthus niruri L is a subtropical plant widely distributing in China and South Asia, which has been used as traditional medicines to treat chronic hepatitis as well as intestinal infections and kidney disease [38–40].”
BackgroundKimura, Y., & Sumiyoshi, M. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.10.016 · Cited by 57 · cited 1×
“The actions of wogonin may be attributed to suppression of VEGF C-induced lymphangiogenesis as postulated by the decrease in VEGF-C-induced VEGFR-3 phosphorylation through suppression of IL-1beta and COX-2 [170].”
BackgroundLi, T., Zhu, R., Dong, Y., Liu, Y., Li, S., & Chen, G. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf400283w · Cited by 56 · cited 1×
“Another study from the same research group also found that penta-oligogalacturonide remarkably increased the liver fatty acid oxidation-related enzyme activities of acyl-CoA oxidase, 3-ketoacyl-CoA thiolase, 2,4-dienoyl-CoA reductase, and carnitine palmitoyltransferase I, which may prevent hyperlipemia in the liver of…”
Self-citationWang, B., Wang, X.-J., Kang, H., Bai, M., Guan, H., Wang, Z.-W., Zan, Y., Song, L., Min, W., Lin, S., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356648 · Cited by 54
Clinical features and management of autoimmune hepatitis
Krawitt, E. L. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3301 · Cited by 53
El‐Shitany, N. A., Hegazy, S. K., & El-desoky, K. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.05.012 · Cited by 52 · cited 1×
“Generally, silymarine and silybinin have not shown any significant side effects or toxicity in previous study, except for the above mentioned ones [225–227].”
Chang, J., Wang, K.-C., Liu, H., Chen, M., Chiang, L., & Lin, C. (2007) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x07004862 · Cited by 51 · cited 1×
“Another research group in Singapore also found that XCHT could inhibit the production of HBV, but the major ingredients contributing to the activity are still not clear [194].”
BackgroundKim, S., & Lee, S. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.10.005 · Cited by 50
Zhu, M., Wang, N., Tsao, S., Yuen, M., Feng, Y., Wan, T. S. K., Man, K., & Feng, Y. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2010.164 · Cited by 50 · cited 1×
“Another study also confirmed that CRAE suppressed HCC growth by targeting on miR-21 and miR-23a [158].”
BackgroundSelf-citationWang, Z., Li, H., Han, X., Yue, X.-L., Cheng, X., Hou, W.-J., Zhang, Y., & Chen, D. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.05.013 · Cited by 50 · cited 1×
“Bupleurum could excessively activate the immune system and might increase the symptoms of auto-immune diseases [230].”
BackgroundBoya, P., Larrea, E., Sola, I., Majano, P.-L., Jiménez, C., Civeira, M.-P., & Prieto, J. (2001) · Hepatology · doi:10.1053/jhep.2001.29002 · Cited by 49 · cited 1×
“Recent studies suggest that NF-κB, Toll-like receptors and β-cathepsin may be involved in fibrosis regulation [117,118].”
BackgroundKang, S. J., Lee, Y. J., Kim, B. M., Kim, Y. J., Woo, H. D., Jeon, H. K., & Chung, H. W. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00280.x · Cited by 48 · cited 1×
“When combining Bupleurum chinense DC with chemotherapy, increased micronuclei frequency and DNA damage have been observed on liver cancer cells [164].”
BackgroundMultitargeted inhibition of hepatic fibrosis in chronic iron-overloaded mice by Salvia miltiorrhiza
Zhang, Y., Zhang, Y., Xie, Y., Gao, Y., Ma, J., Yuan, J., Li, J., Wang, J., Li, L., Zhang, J., et al. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.05.028 · Cited by 48 · cited 1×
“Moreover, Salvia miltiorrhiza Bunge treatment can decrease malondialdehyde content as well as increase glutathione (GSH) content and superoxide dismutase (SOD) activity while it reduced expression of TNF-alpha, IL-1alpha and caspase-3 [53].”
BackgroundChen, M.-H., Chen, J., Tsai, C., Wang, W., Chang, D., Tu, D., & Hsieh, H. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.09.040 · Cited by 48 · cited 1×
“At the same time, XCHT could induce the expression of TNF-alpha to suppress hepatic stellate cell proliferation and collagen formation [198].”
BackgroundMüller, C., Gardemann, A., Keilhoff, G., Peter, D., Wiswedel, I., & Schild, L. (2012) · Phytomedicine · doi:10.1016/j.phymed.2011.12.002 · Cited by 47 · cited 1×
“Further study of the mechanisms revealed that GP enhances the production of nitric oxide (NO) which reduces oxidative stress damage in liver cells and affects the molecular composition of the mitochondrial phospholipid cardiolipin (CL) [85].”
BackgroundChen, L., Zhang, F., Kong, D., Zhu, X., Chen, W., Wang, A., & Zheng, S. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.08.006 · Cited by 47
Liu, S., Wei, W., Li, Y., Lin, X., Shi, K., Cao, X., & Zhou, M. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.09.019 · Cited by 47
Review of Treatment Options for Nonalcoholic Fatty Liver Disease
Corrado, R., Torres, D. M., & Harrison, S. A. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.09.001 · Cited by 46
Hwang (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000163 · Cited by 44 · cited 1×
“) Baill may regulate the body's humoral balance, promote cell-mediated immune responses and has anti-HBV properties [64].”
BackgroundYue, S., Hu, B., Wang, Z., Yue, Z., Wang, F., Zhao, Y. Q., Yang, Z., & Shen, M. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2014.889720 · Cited by 44
Lam, W., Leung, K. T., Law, P. T. W., Lee, S. M., Chan, H. L., Fung, K., Ooi, V. E.-C., & Waye, M. M. Y. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20611 · Cited by 43 · cited 1×
“, found that the ethanolic extract of Phyllanthus niruri L could suppress HBsAg secretion and down-regulate the expression of HBsAg mRNA, with a mechanism that may be related to up-regulation of annexin A7 protein [42].”
BackgroundImpact of matrine on inflammation related factors in rat intestinal microvascular endothelial cells
Suo, Z., Liu, Y., Ferreri, M., Zhang, T., Liu, Z., Mu, X., & Han, B. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.07.023 · Cited by 43 · cited 1×
“These results indicated that matrine could inhibit inflammation in liver and might be beneficial for patients with hepatitis [55].”
BackgroundKorenaga, M., Hidaka, I., Nishina, S., Sakai, A., Shinozaki, A., Gondo, T., Furutani, T., Kawano, H., Sakaida, I., & Hino, K. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02469.x · Cited by 42 · cited 1×
“In addition, it can down-regulate the reactive oxygen species in mice liver [98].”
BackgroundYen, M., Weng, T., Liu, S.-Y., Chai, C., & Lin, C. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.442 · Cited by 42 · cited 1×
“In addition, when compared with the Bupleurum chinense DC, the anti-fibrotic and hepatoprotective effects of Bupleurum kaoi are more significant [138].”
ResultFactors Associated or Related to with Pathological Severity of Nonalcoholic Fatty Liver Disease
Park, K. S., Lee, Y. S., Park, H. W., Seo, S. H., Jang, B. K., Hwang, J. Y., Cho, K. B., Hwang, J. S., Ahn, S. H., Kang, Y. N., et al. (2004) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2004.19.1.19 · Cited by 41 · cited 1×
“The inflammation and a high degree of steatosis will induce hepatocyte necrosis, lipid peroxidation and activation of stellate cells, which play an important role in liver fibrosis [78].”
BackgroundAmin, Z. A., Abdulla, M. A., Ali, H. M., Alshawsh, M. A., & Qadir, S. W. (2012) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.5554 · Cited by 40 · cited 1×
“The main active compounds in Phyllanthus niruri L including quercetin rhamnoside, gallic acid, geraniin and quercetin glucoside have been identified and proved with the properties of anti-bacterial, anti-viral and anti-hepatotoxic effects [41].”
BackgroundRui, W., Xie, L., Liu, X., He, S., Wu, C., Zhang, X., Zhang, L., & Yang, Y. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.10.022 · Cited by 39 · cited 1×
“found that Salvia miltiorrhiza Bunge extracts prevents human HCC on DEN-induced hepatocarcinogenesis by suppressing fibrosis and plasminogen activator inhibitor-1 mRNA transcription in a dose-dependent manner [167].”
BackgroundQu, Y., Zong, L., Xu, M., Dong, Y., & Lu, L. (2015) · Europe PMC (PubMed Central) · Cited by 38
Wan, J., Zhu, Y., Feng, J., Chen, H., Zhang, R., Ni, J., Chen, Z., Hou, L., Liu, Q.-F., Zhang, J., et al. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.05.001 · Cited by 37 · cited 1×
“These results suggested that the new phytochemicals PSA may have therapeutic potential for treating human autoimmune-related hepatitis [57,58].”
BackgroundEffects of Fufang Biejia Ruangan Pills on hepatic fibrosisin vivoandin vitro
Yang, F., Bu-wu, F., & Jian-shi, L. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i32.5326 · Cited by 36 · cited 1×
“Further mechanism study revealed that the suppression of TGF-beta1 and Smad3 expression may contribute to the hepatoprotective effects of BJRG tables [207].”
BackgroundStanca, E., Serviddio, G., Bellanti, F., Vendemiale, G., Siculella, L., & Giudetti, A. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.07.005 · Cited by 36 · cited 1×
“Silybinin also exhibits significant anti-inflammatory effect in cirrhotic rat liver by decreasing the expression of lysophosphatidylcholine acyltransferase (LPCAT) while increasing platelet-activating factor level [135].”
BackgroundRamakrishnan, G., Sundaram, J., Kamaraj, S., Anandakumar, P., & Devaki, T. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1582-1 · Cited by 36 · cited 1×
“As complementary herbal medicine, long term administration of silymarin can inhibit cell proliferation, induce cell apoptosis, and sensitize the detoxification system in HCC cells [161].”
BackgroundZhu, H., Bodenheimer, H. C., Clain, D. J., Min, A. D., & Theise, N. D. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i40.5065 · Cited by 35 · cited 1×
“In alcoholic hepatitis, the damage is usually found in association with fatty liver which we will in a subsequent paragraph [14,15].”
BackgroundBonifaz, V., Shan, Y., Lambrecht, R. W., Donohue, S. E., Moschenross, D. M., & Bonkovsky, H. L. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01833.x · Cited by 34 · cited 1×
“The antiviral mechanism of silymarin is different from interferon which inhibits the JAK/STAT signaling pathway [30].”
BackgroundWang, N., Feng, Y., Cheung, F., Chow, O.-Y., Wang, X., Su, W., & Tong, Y. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-239 · Cited by 34 · cited 1×
“A comparative research on the hepatoprotective action of bear bile and CRAE on experimental liver fibrosis in rats demonstrated that berberine, CRAE, and bear bile all exhibited anti-fibrotic properties on liver fibrosis [124].”
BackgroundSelf-citationMalek, M. A., Hoang, M.-H., Jia, Y., Lee, J. H., Jun, H. J., Lee, D., Lee, H. J., Lee, C., Lee, M. K., Hwang, B. Y., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.020 · Cited by 34
Potential role of β-elemene on histone H1 in the H22 ascites hepatoma cell line
Zhang, H. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.891 · Cited by 31
Parajuli, D. R., Zhao, Y., Jin, H., Chi, J. H., Li, S. Y., Kim, Y., Sohn, D. H., & Lee, S. H. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0425-2 · Cited by 29
Self-citationMeta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B
Wei, F., Liu, S.-K., Liu, X.-Y., Li, Z.-J., Li, B., Zhou, Y., Zhang, H.-Y., & Li, Y.-W. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1789-1 · Cited by 29
Sho-saiko-to Prevents Liver Fibrosis Induced by Bile Duct Ligation in Rats
Chen, M.-H., Chen, J., Tsai, C., Wang, W., Chang, D., Lin, C., & Hsieh, H. (2004) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x04001862 · Cited by 28 · cited 1×
“More importantly, XCHT exhibited remarkable antifibrogenic effect through decreasing the expression of TIMP-1 and procollagen alpha1 types (I) and (III) in liver [197].”
BackgroundZhou, L., Li, X., Chen, X., Li, Z., Liu, X., Zhou, S., Zhong, Q., Yi, T., Wei, Y., Zhao, X., et al. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.04.024 · Cited by 27 · cited 1×
“Thus, CPT-TMC may be a potential safe and effective therapeutic agent for liver cancer treatment [179].”
BackgroundZhang, J., Ni, J., Chen, Z.-H., Li, X., Zhang, R.-J., Tang, W., Zhao, W., Yang, Y., & Zuo, J. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.101 · Cited by 27 · cited 1×
“These results suggested that the new phytochemicals PSA may have therapeutic potential for treating human autoimmune-related hepatitis [57,58].”
BackgroundSilymarin in the treatment of chronic liver diseases: past and future
Fehér, J., & Lengyel, G. (2008) · Orvosi Hetilap · doi:10.1556/oh.2008.28519 · Cited by 26 · cited 1×
“According to previous studies, the curative effects of silymarin in alcoholic and non-alcoholic steatohepatitis are widely recognized [99].”
ResultJia, X., Dang, S., Cheng, Y., Zhang, X., Li, M., Li, Y., & Li, S. (2012) · 中医杂志:英文版 · doi:10.1016/s0254-6272(13)60048-5 · Cited by 24 · cited 1×
“In vivo studies found that saikosaponin D can inhibit HCC development and metastasis by decreasing the expression of syndecan-2, MMP-2, MMP-13 in rat liver cells [166].”
BackgroundSelf-citationWood, N. J. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.95 · Cited by 23 · cited 1×
“Chronic liver diseases remain as one of the most serious health problems worldwide, which may affect more than 10% of the world population [1].”
BackgroundWang, R., Mi, H.-M., Li, H., Zhao, S.-X., Yan-hong, J. I. A., & Nan, Y. (2015) · PubMed Central · Cited by 20
The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease.
Chou, S.-C., Chen, K.-W., Hwang, J.-S., Lu, W.-T., Chu, Y., Lin, J., Chang, H.-J., & See, L. (2006) · PubMed · Cited by 20
Zuo, C., Xia, M., Wu, Q., Zhu, H., LIU, J., & Liu, C. (2014) · Oncology Letters · doi:10.3892/ol.2014.2727 · Cited by 19 · cited 1×
“So far, the treatment for liver cancer is limited, the later stage or higher-grade liver cancer patients will ordinarily have poor prognosis [154].”
BackgroundTwo-year results of a randomised double-blinded trial evaluating silymarin for chronic hepatitis C
Strickland, G. T., Tanamly, M. D., Tadros, F., Labeeb, S., Makld, H., Nessim, D., Mikhail, N. N. H., Magder, L. S., Afdhal, N. H., Medhat, A., et al. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2005.03.001 · Cited by 19
Diagnóstico y tratamiento de los síndromes de sobreposición de hepatitis autoinmune
Aguilar-Nájera, O., Velasco-Zamora, J. A., & Torre, A. (2015) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2015.04.001 · Cited by 18
Jin, J. (2010) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20100313 · Cited by 17 · cited 1×
“Another study of hyperlipidemia rats showed different anti-steatosis mechanisms of HLJD and confirmed that the activation of lipid metabolism enzyme and the increased expressions of LDLR and PPAR-gamma are important in preventing liver steatosis in the rats [204].”
BackgroundOverlap syndromes of autoimmune hepatitis: diagnosis and treatment
Aguilar-Nájera, O., Velasco-Zamora, J. A., & Torre, A. (2015) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2015.07.001 · Cited by 16 · cited 1×
“Budesonide with azathioprine may have potential therapeutic effects for autoimmune hepatitis, but the durability of response and target population still need further study [22].”
BackgroundHerb‐induced autoimmune‐like hepatitis in C57 BL /6J mice
Wang, J., Lee, C., Pan, P., Chang, W., Chiu, J., Chen, W., & Shyr, Y. (2013) · Liver International · doi:10.1111/liv.12266 · Cited by 13 · cited 1×
“Some clinical studies have confirmed that the association of medicinal herbs containing Scutellaria baicalensis Georgi and Bupleurum chinense DC may induce liver fibrosis [239].”
BackgroundSandahl, T. D. (2014) · PubMed · Cited by 12
Lu, Y., Hong, T. G., Jin, M., et al. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1944 · Cited by 12
Kwon, R. H., & Ha, B. J. (2014) · Toxicological Research · doi:10.5487/tr.2014.30.4.291 · Cited by 11 · cited 1×
“) Baill has been used in Chinese medicine for treating jaundice, gonorrhea and edema as well as reversing liver fibrosis [128,129].”
MethodGeneral aspects of the treatment of alcoholic hepatitis
Babineaux, M. J., & Anand, B. S. (2011) · World Journal of Hepatology · doi:10.4254/wjh.v3.i5.125 · Cited by 10 · cited 1×
“Unfortunately, a large proportion of patients do not respond to these drugs [21].”
BackgroundZhao, Z. (2007) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20070610 · Cited by 8 · cited 1×
“BJRG tablet could inhibit the development of fibrosis by decreasing the mRNA expressions of connective tissue growth factor in rats [205].”
BackgroundZhao, M., Han, D. W., Ma, X. H., et al. (1983) · PubMed · Cited by 7
Zhou, J. F., Chen, X., Liu, S., Fu, B., Hong, Q., & Wang, S. (2014) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-014-1784-0 · Cited by 6 · cited 1×
“Another study using renal cells also confirmed the anti-fibrosis effects of BJRG tablet and the mechanism may be related with its suppression on TIMP-1 and type I and III procollagen expression [206].”
BackgroundCASE REPORT: Chronic Hepatitis C and Autoimmune Cholangitis: A Case Study and Literature Review
Sánchez-Pobre, P., González‐Lois, C., Paz, E., Colina, F., Castellano, G., Muñoz‐Yagüe, T., Rodríguez, S., Yela, C., Álvarez, V., & Solis-Herruzo, J. A. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1015341625934 · Cited by 5
Cited by
Zhuang, X., Li, L., Liu, T., Zhang, R., Yang, P., Wang, X., & Dai, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1037814 · Cited by 88
Cyanotherapeutics: An emerging field for future drug discovery
Tiwari, A. K., & Tiwari, B. S. (2020) · Applied Phycology · doi:10.1080/26388081.2020.1744480 · Cited by 49
Metadata
- Authors
- Hong, M., Li, S., Tan, H., Wang, N., Tsao, S.-W., & Feng, Y.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2015-12-02
- Volume
- 16
- Issue
- 12
- Pages
- 28705-28745
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2182298897
- Cited by
- 194
- References
- 177
- FWCI
- 26.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.